Tahinamandranto Rasamoelina

Dr. Tahinamandranto Rasamoelina

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
MRMarie Gladys ROBERT
Marie Gladys ROBERT
MCMuriel Cornet
Muriel Cornet
AHAurélie HENNEBIQUE
Aurélie HENNEBIQUE
TRTahinamandranto Rasamoelina
Tahinamandranto Rasamoelina
YCYvan Caspar
Yvan Caspar
DMDanièle Maubon
Danièle Maubon
The implementation of MALDI-TOF MS in medical microbiology laboratories has revolutionized practices and significantly reduced turnaround times of identification processes. However, although bacteriology quickly benefited from the contributions of this technique, adjustments were necessary to accommodate the specific characteristics of fungi. MALDI-TOF MS is now an indispensable tool in clinical mycology laboratories, both for the identification of yeasts and filamentous fungi, and other innovative uses are gradually emerging. Based on the practical experience of our medical mycology laboratory, this review will present the current uses of MALDI-TOF MS and the adaptations we implemented, to allow their practical execution in a daily routine. We will also introduce some less mainstream applications, like those for fungemia, or even still under development, as is the case for the determination of sensitivity to antifungal agents or typing methods.

9 April 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
DMDanièle Maubon
Danièle Maubon
CGCecile Garnaud
Cecile Garnaud
LRLala Soavina Ramarozatovo
Lala Soavina Ramarozatovo
FRFahafahantsoa Rapelanoro Rabenja
Fahafahantsoa Rapelanoro Rabenja
MCMuriel Cornet
Muriel Cornet
TRTahinamandranto Rasamoelina
Tahinamandranto Rasamoelina
Chromoblastomycosis and sporotrichosis are the two main implantation mycoses that are now recognized as fungal neglected tropical diseases (NTDs). Their laboratory diagnosis mainly relies on direct microscopy, histopathology, and identification of the fungus by culture. However, to be appropriately used, these techniques require mycological expertise that is not widely available and may be absent in peripheral health care facilities in endemic areas. In addition, they lack sensitivity and specificity, and the culture for isolation and identification can have a long time-to-results period. Molecular methods, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), have been developed in well-equipped reference laboratories. They greatly improve the rapidity and accuracy of diagnosis; in particular, for species identification. Recently, PCR and sequencing have paved the way for more user-friendly point-of-care tests, such as those based on LAMP or RCA technologies, which can be used in basic healthcare settings and even in field consultations.

15 November 2023 in Viruses
Verified
Journal Article
Open access
PDF file
FRFetra Angelot RAKOTOMALALA
Fetra Angelot RAKOTOMALALA
JBJulie Bouillin
Julie Bouillin
SRSantatriniaina Hajanirina Randriarimanana
Santatriniaina Hajanirina Randriarimanana
GTGuillaume Thaurignac
Guillaume Thaurignac
LMLuca Maharavo
Luca Maharavo
AAAhidjo Ayouba
Ahidjo Ayouba
To estimate the prevalence of IgG antibodies against six arboviruses in people living with HIV-1 (PLWHIV) in Madagascar, we tested samples collected between January 2018 and June 2021. We used a Luminex-based serological assay to detect IgG antibodies against antigens from Dengue virus serotypes 1–4 (DENV1–4), Zika virus (ZIKV), West Nile virus (WNV), Usutu virus (USUV), Chikungunya virus (CHIKV), and O’nyong nyong virus (ONNV). Of the 1036 samples tested, IgG antibody prevalence was highest for ONNV (28.4%), CHIKV (26.7%), WNV-NS1 (27.1%), DENV1 (12.4%), USUV (9.9%), and DENV3 (8.9%). ZIKV (4.9%), DENV2 (4.6%), WNV-D3 (5.1%), and DENV4 (1.4%) were lower. These rates varied by province of origin, with the highest rates observed in Toamasina, on the eastern coast (50.5% and 56.8%, for CHIKV and ONNV, respectively). The seroprevalence increased with age for DENV1 and 3 (p = 0.006 and 0.038, respectively) and WNV DIII (p = 0.041). The prevalence of IgG antibodies against any given arborvirus varied over the year and significantly correlated with rainfalls in the different areas (r = 0.61, p = 0.036). Finally, we found a significant correlation between the seroprevalence of antibodies against CHIKV and ONNV and the HIV-1 RNA plasma viral load. Thus, PLWHIV in Madagascar are highly exposed to various arboviruses. Further studies are needed to explain some of our findings.

17 March 2025 in Infectious Diseases of Poverty
Verified
Journal Article
Open access
PDF file
ELEva Lorenz
Eva Lorenz
RRRavo Razafindrakoto
Ravo Razafindrakoto
PRPia Rausche
Pia Rausche
ZRZaraniaina Tahiry Rasolojaona
Zaraniaina Tahiry Rasolojaona
NRNantenaina Matthieu Razafindralava
Nantenaina Matthieu Razafindralava
Daniela FuscoDaniela Fusco
Daniela Fusco
Background: Schistosoma haematobium and S. mansoni are endemic in Madagascar, but reliable diagnostic tools are often lacking, contributing to exacerbate transmission and morbidity. This study evaluated the diagnostic accuracy of three tests for schistosome infection in Malagasy adults from areas of medium to high endemicity. Methods: This cross-sectional study enrolled adults from three primary health care centres in Madagascar. Urine and blood samples were tested for schistosome infection using polymerase chain reaction (PCR), up-converting reporter particle lateral flow for the circulating anodic antigen (UCP-LF CAA), and point-of-care circulating cathodic antigen (POC-CCA) tests. Bayesian latent class models were used to assess diagnostic accuracies and disease prevalence. Results: Of 1339 participants, 461 were from S. haematobium and 878 from S. mansoni endemic areas. Test detection rates were 52% (POC-CCA), 60% (UCP-LF CAA), and 66% (PCR) in the S. haematobium area, and 54%, 55%, and 59% respectively in the S. mansoni area. For S. haematobium, PCR and UCP-LF CAA showed high sensitivity (Se, median 95.2% and 87.8%) but moderate specificity (Sp, 60.3% and 66.2%), while POC-CCA performed moderately (Se: 64.5%; Sp: 59.6%). For S. mansoni, PCR and POC-CCA demonstrated high diagnostic accuracy (Se > 90%, Sp > 80%), while UCP-LF CAA showed good sensitivity (79.9%) but moderate specificity (69.7%). Conclusions: While population-level prevalence estimates were similar across tests, individual-level agreement was only low to moderate. Our findings suggest that optimal diagnostic strategies should be tailored to specific endemic settings, continued development of accurate diagnostics suitable for highly endemic settings remains a priority. Graphical

4 October 2024 in Infection, Genetics and Evolution
Verified
Journal Article
Open access
FRFetra Angelot Rakotomalala
Fetra Angelot Rakotomalala
CBChristelle Butel
Christelle Butel
TRTahinamandranto Rasamoelina
Tahinamandranto Rasamoelina
LSLaetitia Serrano
Laetitia Serrano
NVNicole Vidal
Nicole Vidal
AAAhidjo Ayouba
Ahidjo Ayouba
Background and objectives Data on HIV drug resistance in Madagascar are rare and outdated. In this study, we assessed the prevalence of HIV drug resistance mutations to antiretrovirals (ARVs) and genetic diversity of circulating strains in treatment-naive people living with HIV (PLHIV) in Madagascar. Materials and methods We amplified the protease (PR), fragments of the Reverse Transcriptase (RT) and Integrase (IN) genes according to the French ANRS protocol. The amplicons were sequenced using next-generation sequencing technology on an Illumina platform (MiSeq). We determined HIV-1 subtypes through phylogenetic analysis using maximum likelihood in PhyML. Resistance interpretation was performed using the Stanford algorithm (version 9.5.1). Results: We included 239 HIV-infected adults and children, sampled between January 2019 and November 2023, with a median age of 30 years and a mean plasma HIV viral load of 6.3 Log copies/mL. We sequenced at least one genomic fragment (PR or RT or IN) of the 239 samples, but 9 were excluded from analysis (mean depth < 10,000×). Phylogenetic analysis of 230 sequences revealed the presence of subtype C (33.91 %), A1 (11.30 %), B (11.30 %), CRF02_AG (9.56 %), subtype G (3.04 %), subtype D (0.43 %), CRF01_AE (0.43 %), and a significant proportion of unique recombinant forms (URFs) (30.30 %). The prevalence of transmitted drug resistance (TDR) was 4.95 % (10/202) among patients aged 15 years and older. When stratified by ARV class, this prevalence was 4.79 % for non-nucleoside reverse transcriptase inhibitors (NNRTIs), 0.59 % for Nucleoside Reverse Transcriptase inhibitors (NRTIs), and 0.50 % for integrase strand transfer inhibitors (INSTIs). Among children under 15 years old (n = 28), the prevalence of TDR was 14.28 % (4/28), with all mutations conferring resistance to NNRTIs. No mutation conferring resistance to protease inhibitors was found, neither in children nor in adults. Conclusion: Our results show a low prevalence of ARV resistance mutations among adult treatment-naive PLHIV in Madagascar. In children under 15 years old, 92 % were infants under two years old, the high resistance rate is likely related to mother-to-child transmission. No resistance mutation to dolutegravir was detected. We also observed high frequencies of subtypes C, B, A1 and a high proportion of URFs, highlighting an ongoing dynamic epidemic.

28 August 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
LMLuca Maharavo
Luca Maharavo
EWEmilie Westeel
Emilie Westeel
JBJean-Luc Berland
Jean-Luc Berland
MRMihaja Raberahona
Mihaja Raberahona
HRHonintsoa Rasoanaivo
Honintsoa Rasoanaivo
TRTahinamandranto Rasamoelina
Tahinamandranto Rasamoelina
Acute respiratory infections (ARIs) are challenging to diagnose due to overlapping symptoms among pathogens. During the COVID-19 pandemic in Antananarivo (